1. Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481)

   • Shinichi Kurakata
   • Mikiko Tomatsu
   • Kikuo Nomoto

   Original articles Pages: 71 - 79

2. Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucin

   • M. R. Price
   • M. Sekowski
   • R. W. Baldwin

   Original articles Pages: 80 - 84

3. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice

   • Nigel C. Phillips
   • Ming-Sound Tsao

   Original articles Pages: 85 - 90

4. Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen

   • Jerzy Nowak
   • Edward P. Cohen
   • Lloyd H. Graf Jr

   Original articles Pages: 91 - 96

5. The effects of staphylococcal protein A on human lymphokine-activated killer cell induction

   • Robert A. Lindemann
   • Kameshwar P. Singh
   • Rishab K. Gupta

   Original articles Pages: 97 - 102

6. Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity

   • David M. Finkelstein
   • Richard G. Miller

   Original articles Pages: 103 - 108

7. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: Increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine

   • Brahma S. Sharma
   • Louisa Balazs
   • Roland K. Robins

   Original articles Pages: 109 - 114

8. Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity

   • Paul A. van de Wiel
   • Anita van der Pijl
   • Nanne Bloksma

   Original articles Pages: 115 - 120

9. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer

   • Jette Vibe-Petersen
   • Niels Tvede
   • Vagn Andersen

   Original articles Pages: 121 - 127

10. Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulation

    • Claudio Fortis
    • Elisabetta Ferrero
    • Claudio Rugarli

    Original articles Pages: 128 - 132

11. Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias

    • Seah H. Lim
    • Colin Worman
    • Anthony Goldstone

    Original articles Pages: 133 - 137